Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy
Single-cell RNA-seq · human · 23 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 23 samples: 11 × Normal Voluntee vs 7 × CAR-T Enterocolitis vs 5 × CAR-T ControlGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE322796_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1431538 and SRA study SRP680742. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 23 samples.
How we read this: 3 replicated groups read from 23 sample titles; they account for 23 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9558942 CAR-T Enterocolitis 1 CAR-T Enterocolitis
- GSM9558943 CAR-T Enterocolitis 2 CAR-T Enterocolitis
- GSM9558945 CAR-T Enterocolitis 3 CAR-T Enterocolitis
- GSM9558946 CAR-T Enterocolitis 4 CAR-T Enterocolitis
- GSM9558947 CAR-T Control 2 CAR-T Control
- GSM9558948 CAR-T Control 3 CAR-T Control
- GSM9558949 CAR-T Control 4 CAR-T Control
- GSM9558950 CAR-T Control 5 CAR-T Control
- GSM9558951 CAR-T Control 7 CAR-T Control
- GSM9558952 Normal Volunteer 1 Normal Voluntee
- GSM9558953 Normal Volunteer 2 Normal Voluntee
- GSM9558954 Normal Volunteer 3 Normal Voluntee
- GSM9558955 Normal Volunteer 4 Normal Voluntee
- GSM9558956 Normal Volunteer 5 Normal Voluntee
- GSM9558957 Normal Volunteer 6 Normal Voluntee
- GSM9558958 Normal Volunteer 7 Normal Voluntee
- GSM9558959 Normal Volunteer 8 Normal Voluntee
- GSM9558960 Normal Volunteer 11 Normal Voluntee
- GSM9558961 Normal Volunteer 12 Normal Voluntee
- GSM9558962 Normal Volunteer 14 Normal Voluntee
- GSM9742309 CAR-T Enterocolitis 5 CAR-T Enterocolitis
- GSM9742310 CAR-T Enterocolitis 6 CAR-T Enterocolitis
- GSM9742311 CAR-T Enterocolitis 7 CAR-T Enterocolitis
- GSE271915 Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy 14 samples shares car-t, bcma, therapy
- GSE304878 Single-cell multi-omics profiling of PBMCs from SLE patients pre- and post-dual-target (BCMA/CD19) CAR-T therapy 30 samples shares car-t, bcma, therapy
- GSE274187 CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy 23 samples shares car-t, bcma, therapy
- GSE246342 CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy I 18 samples shares car-t, bcma, therapy
- GSE255977 Genetic Disruption of Blimp-1 Drastically Augments the Anti-Tumour Efficacy of BCMA-Targeting CAR-T Cells 8 samples shares car-t, bcma
- GSE289423 Enhanced Antitumoral Activity of the Academic CAR-T ARI0002h Against Normal and Low BCMA Expressing Myeloma Cells After Incorporating a Transmembrane CD28 Domain 8 samples shares car-t, bcma
- GSE280754 Single cell RNA sequencing of TSCM predominnant allogeneic anti-BCMA CAR-T cells 24 samples shares car-t, bcma
- GSE289406 Anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy bb21217 for relapsed and refractory multiple myeloma: results from the phase 1 CRB-402 study 75 samples shares bcma, therapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.